Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 18.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.50
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Applications Announcement

17 May 2022 12:00

RNS Number : 7986L
Belluscura PLC
17 May 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU) NO.596/2014, WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

 

Belluscura plc

("Belluscura", the "Company" or the "Group")

 

Allotment of shares

 

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced on 13 May 2022 the result of a Placing to raise approximately £6.0 million by way of the issue of 7,058,824 Placing Shares at an issue price of 85 pence per ordinary share.

 

The Placing Shares will be issued credited as fully paid and will rank pari passu with the Existing Ordinary Shares and represent approximately 6.2 per cent. of the Existing Ordinary Shares.

 

The Company has allotted, subject to First Admission (as defined below), 1,137,630 EIS/VCT Placing Shares and, subject to Second Admission (as defined below), 5,921,194 General Placing Shares.

 

Admission and dealings

Application has been made for 1,137,630 EIS/VCT Placing Shares, issued pursuant to the Placing, to be admitted to trading on AIM which is expected to occur at 8.00 a.m. on 18 May 2022 ("First Admission").

 

Application has also been made for 5,921,194 General Placing Shares, also issued pursuant to the Placing, to be admitted to trading on AIM which is expected to occur at 8.00 a.m. on 19 May 2022 ("Second Admission").

 

Total voting rights

Following First Admission, the issued share capital of the Company will comprise 115,306,407 Ordinary Shares, none of which are held in treasury. Therefore, following First Admission, the total number of Ordinary Shares with voting rights in the Company will be 115,306,407 Ordinary Shares, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Following Second Admission, the issued share capital of the Company will comprise 121,227,601 Ordinary Shares, none of which are held in treasury. Therefore, following Second Admission, the Enlarged Share Capital of the Company and total number of Ordinary Shares with voting rights in the Company will be 121,227,601 Ordinary Shares, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used in this announcement have the meanings given to them in the Launch Announcement of 12 May 2022, unless the context provides otherwise.

 

For further information please contact:

 

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via Walbrook PR

Anthony Dyer, Chief Financial Officer

 

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

 

Dowgate Capital Limited (Sole Broker and Sole Bookrunner)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com

Paul McManus / Sam Allen

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSARMMTMTIBBAT
Date   Source Headline
28th Mar 20247:00 amRNSTotal Voting Rights
8th Mar 20244:36 pmRNSOffer Closed
7th Mar 20248:30 amRNSCancellation of Listing and trading
4th Mar 20247:00 amRNSAcceptances level
26th Feb 20247:00 amRNSAcceptances level
22nd Feb 20243:00 pmRNSAcceptances level, issue of equity & AIM Admission
19th Feb 20247:00 amRNSAcceptances level & offer closing
15th Feb 20243:51 pmRNSAcceptances level, issue of equity & AIM Admission
13th Feb 20247:00 amRNSDistribution Agreement & New VP North America
13th Feb 20247:00 amRNSAcceptances Level
12th Feb 20241:44 pmGNWForm 8.3 - Belluscura PLC
9th Feb 20248:16 amRNSOffer becomes wholly unconditional
8th Feb 20243:31 pmRNSAcceptances level, issue of equity & AIM Admission
7th Feb 20244:20 pmRNSOffer Unconditional (subject to AIM Admission)
7th Feb 202411:13 amRNSForm 8.3 - Belluscura Plc
5th Feb 20241:30 pmRNSResult of General Meeting
5th Feb 20247:00 amRNSAcceptances received in respect of the Offer
2nd Feb 202411:24 amRNSForm 8 (OPD) Belluscura plc
2nd Feb 202411:18 amRNSForm 8 (OPD) TMT Acquisition plc
1st Feb 20246:16 pmRNSForm 8 (OPD) TMT Acquisition plc - Amended
1st Feb 20246:14 pmRNSForm 8 (OPD) Belluscura plc - Amended
1st Feb 20242:34 pmGNWForm 8.3 - Belluscura PLC
29th Jan 202411:42 amRNSForm 8.3 - Belluscura PLC
24th Jan 20246:24 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20246:17 pmRNSForm 8.3 - Belluscura
24th Jan 20246:02 pmRNSForm 8.3 - Belluscura PLC - Replacement
24th Jan 20245:49 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20243:25 pmRNSForm 8.3 - Belluscura plc
24th Jan 20243:14 pmRNSHolding(s) in Company
24th Jan 202410:45 amRNSForm 8.3 - Belluscura Plc
23rd Jan 20246:06 pmRNSForm 8.3 - Belluscura plc
23rd Jan 20245:39 pmRNSForm 8.3 - BELLUSCURA PLC
19th Jan 20241:30 pmRNSPosting of Offer Document and Circular
8th Jan 20241:01 pmGNWForm 8.3 - Belluscura PLC
22nd Dec 202312:10 pmRNSExtension to deadline for posting Offer Document
20th Dec 20237:00 amRNSChinese registration and Trading Update
19th Dec 20231:04 pmGNWForm 8.3 - Belluscura PLC
13th Dec 20232:43 pmGNWForm 8.3 - Belluscura PLC
12th Dec 20237:00 amRNSBelluscura Receives Approval in Singapore
28th Nov 20235:00 pmRNSExtension to deadline for posting Offer Document
24th Nov 20232:06 pmGNWForm 8.3 - Belluscura PLC
16th Nov 202312:20 pmRNSForm 8.3 - Belluscura PLC
16th Nov 202312:12 pmRNSForm 8.3 - Belluscura PLC
9th Nov 202311:04 amRNSForm 8.3 - TMT Acquisition PLC
8th Nov 20235:52 pmRNSForm 8.3 - TMT Acquisition plc
8th Nov 202311:44 amRNSForm 8.3 - Belluscura PLC
7th Nov 20233:35 pmRNSForm 8.3 - TMT Acquisition PLC
2nd Nov 20236:15 pmRNSForm 8.3 - TMT Acquisition
2nd Nov 20234:23 pmPRNForm 8.3 - Belluscura Plc
1st Nov 20233:03 pmRNSReplacement: Rule 2.7 Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.